SCHEMBL3928289

SCHEMBL3928289

CCCCC(=O)Cc1c(O)cc(O)c(Cl)c1O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ IAPP P10997 4/20 0.44
▸ FFAR1 O14842 1/20 0.41
▸ PLA2G2A P14555 1/20 0.41
▸ PLA2G5 P39877 1/20 0.41
▸ MEN1 O00255 1/20 0.39
▸ KMT2A Q03164 1/20 0.39
▸ PAK1 Q13153 1/20 0.39
▸ CYP1A2 P05177 1/20 0.35
▸ CYP3A4 P08684 1/20 0.35
▸ CYP2C8 P10632 1/20 0.35
▸ CYP2C9 P11712 1/20 0.35
▸ CYP2B6 P20813 1/20 0.35
▸ CYP2C19 P33261 1/20 0.35
▸ CES2 O00748 1/20 0.35
▸ CES1 P23141 1/20 0.35
▸ HPGD P15428 2/20 0.35
▸ NPC1 O15118 1/20 0.35
▸ MAPK1 P28482 1/20 0.35
▸ HTT P42858 1/20 0.35
▸ RAB9A P51151 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28602299 0.76 ACLY (0.33) FFAR1MEN1KMT2ACYP1A2CYP3A4
SCHEMBL28612715 0.70 IAPP (0.42) IAPPCYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL3515237 0.70 PLA2G2A (0.76) FFAR1PLA2G2APLA2G5MEN1KMT2A
SCHEMBL28715519 0.67 IAPP (0.47) IAPPMEN1KMT2ACYP3A4HPGD
SCHEMBL31383411 0.67 IAPP (0.55) IAPPCYP1A2CYP3A4CYP2C8CYP2C9
SCHEMBL28700300 0.67 IAPP (0.38) IAPPMEN1KMT2ACYP1A2CYP3A4
SCHEMBL18371595 0.66 CYP19A1 (0.53) MEN1KMT2ACYP3A4HPGDNPC1
SCHEMBL18391825 0.65 CYP19A1 (0.51) MEN1KMT2ACYP3A4HPGDNPC1
SCHEMBL1538218 0.65 ALDH1A1 (0.58) IAPPHPGDNPC1MAPK1RAB9A
SCHEMBL28602301 0.65 IAPP (0.39) IAPPFFAR1PLA2G2APLA2G5MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009011870-A1 REDUCTION OF BETA-AMYLOID LEVELS BY TREATMENT WITH THE SMALL MOLECULE DIFFERENTIATION-INDUCING FACTOR THE GENERAL HOSPITAL CORPORATION (US) 2009-01-22 — — WO disclosed
Send feedback